A Study of Multiple Doses of LY2922470 in Participants With Diabetes

Inclusion Criteria: * Must be a male, or a female who cannot become pregnant, and who has type 2 diabetes * Have a glycated hemoglobin (HbA1c) value of greater than or equal to 6.5% and less than or equal to 11% at screening * Do not have any change to their diabetes treatment (exercise with or without metformin) for at least 4 weeks prior to screening * Have a screening body mass index (BMI) of 18.0 to 45.0 kilograms per square meter (kg/m\^2) * Have blood pressure, pulse rate, blood and urine laboratory test results acceptable for the study Exclusion Criteria: * Are currently participating in another clinical study or completed one in the last 30 days * Have a history of significant heart, lung, liver, kidney, stomach or brain disease, or have any medical problems which may cause an increased risk during the study * Have electrocardiogram (ECG) readings that are not suitable for the study * Are infected with hepatitis B or hepatitis C * Are infected with human immunodeficiency virus (HIV) * Have donated blood equal to or more than 500 mL within 56 days before the first dose of drug or have donated plasma within 7 days before the first dose or provided any blood donation within the last month from screening